GPD1
Glicerol-3-fosfat dehidrogenaza 1 je protein koji je kod ljudi kodiran genom GPD1.[5]
Aminokiselinska sekvenca
urediDužina polipeptidnog lanca je 349 aminokiselina, a molekulska težina 37.568 Da.[6]
- Simboli
C: Cistein
D: Asparaginska kiselina
E: Glutaminska kiselina
F: Fenilalanin
G: Glicin
H: Histidin
I: Izoleucin
K: Lizin
L: Leucin
M: Metionin
N: Asparagin
10 | 20 | 30 | 40 | 50 | ||||
---|---|---|---|---|---|---|---|---|
MASKKVCIVG | SGNWGSAIAK | IVGGNAAQLA | QFDPRVTMWV | FEEDIGGKKL | ||||
TEIINTQHEN | VKYLPGHKLP | PNVVAVPDVV | QAAEDADILI | FVVPHQFIGK | ||||
ICDQLKGHLK | ANATGISLIK | GVDEGPNGLK | LISEVIGERL | GIPMSVLMGA | ||||
NIASEVADEK | FCETTIGCKD | PAQGQLLKEL | MQTPNFRITV | VQEVDTVEIC | ||||
GALKNVVAVG | AGFCDGLGFG | DNTKAAVIRL | GLMEMIAFAK | LFCSGPVSSA | ||||
TFLESCGVAD | LITTCYGGRN | RKVAEAFART | GKSIEQLEKE | LLNGQKLQGP | ||||
ETARELYSIL | QHKGLVDKFP | LFMAVYKVCY | EGQPVGEFIH | CLQNHPEHM |
Funkcija
urediOvaj gen kodira člana NAD-ovisne porodice glicerol-3-fosfat dehidrogenaza. Kodirani protein ima ključnu ulogu u metabolizmu ugljikohidrata i lipida, katalizirajući reverzibilnu konverziju dihidroksiaceton-fosfata (DHAP) i reduciranog nikotin-adenin dinukleotida (NADH) u glicerol-3-fosfat (G3P) i NAD+.
Kodirani citosolni protein i mitohondrijska glicerol-3-fosfat dehidrogenaza također tvore šatl glicerol-fosfata, koji olakšava prijenos redukcijskih ekvivalenata iz citosola u mitohondrije.
Mutacije u ovom genu uzrok su prolazne dojenačke hipertrigliceridemije. Za ovaj gen uočene su Alternativno prerađene varijante transkripta koje kodiraju više izoformi .
Reference
uredi- ^ a b c GRCh38: Ensembl release 89: ENSG00000167588 - Ensembl, maj 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000023019 - Ensembl, maj 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Entrez Gene: Glycerol-3-phosphate dehydrogenase 1". Pristupljeno 23. 3. 2017.
- ^ "UniProt, P21695". Pristupljeno 10. 8. 2021.
Dopunska literatura
uredi- Gudayol M, Vidal J, Usac EF, Morales A, Fabregat ME, Fernández-Checa JC, Novials A, Gomis R (2001). "Identification and functional analysis of mutations in FAD-binding domain of mitochondrial glycerophosphate dehydrogenase in caucasian patients with type 2 diabetes mellitus". Endocrine. 16 (1): 39–42. doi:10.1385/ENDO:16:1:39. PMID 11822825. S2CID 30120853.
- Swierczynski J, Zabrocka L, Goyke E, Raczynska S, Adamonis W, Sledzinski Z (2003). "Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans". Mol. Cell. Biochem. 254 (1–2): 55–9. doi:10.1023/a:1027332523114. PMID 14674682. S2CID 25108711.
- Ou X, Ji C, Han X, Zhao X, Li X, Mao Y, Wong LL, Bartlam M, Rao Z (2006). "Crystal structures of human glycerol 3-phosphate dehydrogenase 1 (GPD1)". J. Mol. Biol. 357 (3): 858–69. doi:10.1016/j.jmb.2005.12.074. PMID 16460752.
- Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP (2006). "GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle". Physiol. Genomics. 27 (2): 114–21. doi:10.1152/physiolgenomics.00045.2006. PMID 16849634.
- MacDonald MJ, Longacre MJ, Langberg EC, Tibell A, Kendrick MA, Fukao T, Ostenson CG (2009). "Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes". Diabetologia. 52 (6): 1087–91. doi:10.1007/s00125-009-1319-6. PMC 2903059. PMID 19296078.
- Krasnov GS, Oparina NIu, Khankin SL, Mashkova TD, Ershov AN, Zatsepina OG, Karpov VL, Beresten' SF (2009). "[Colorectal cancer 2D-proteomics: identification of altered protein expression]". Mol. Biol. (Mosk.) (jezik: ruski). 43 (2): 348–56. doi:10.1134/s0026893309020186. PMID 19425502. S2CID 30196165.
- Guindalini C, Lee KS, Andersen ML, Santos-Silva R, Bittencourt LR, Tufik S (2010). "The influence of obstructive sleep apnea on the expression of glycerol-3-phosphate dehydrogenase 1 gene". Exp. Biol. Med. (Maywood). 235 (1): 52–6. doi:10.1258/ebm.2009.009150. PMID 20404019. S2CID 207194967.
- Basel-Vanagaite L, Zevit N, Har Zahav A, Guo L, Parathath S, Pasmanik-Chor M, McIntyre AD, Wang J, Albin-Kaplanski A, Hartman C, Marom D, Zeharia A, Badir A, Shoerman O, Simon AJ, Rechavi G, Shohat M, Hegele RA, Fisher EA, Shamir R (2012). "Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1". Am. J. Hum. Genet. 90 (1): 49–60. doi:10.1016/j.ajhg.2011.11.028. PMC 3257852. PMID 22226083.
- Joshi M, Eagan J, Desai NK, Newton SA, Towne MC, Marinakis NS, Esteves KM, De Ferranti S, Bennett MJ, McIntyre A, Beggs AH, Berry GT, Agrawal PB (2014). "A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia". Eur. J. Hum. Genet. 22 (10): 1229–32. doi:10.1038/ejhg.2014.8. PMC 4169545. PMID 24549054.